Abstract
Injection-site-associated sarcomas (ISAS), commonly arising at the site of routine vaccine administration, afflict as many as 22,000 domestic cats annually in the USA. These tumors are typically more aggressive and prone to recurrence than spontaneous sarcomas (non-ISAS), generally receiving a poorer long-term prognosis and warranting a more aggressive therapeutic approach. Although certain clinical and histological factors are highly suggestive of ISAS, timely diagnosis and optimal clinical management may be hindered by the absence of definitive markers that can distinguish between tumors with underlying injection-related etiology and their spontaneous counterpart. Specific nonrandom chromosome copy number aberrations (CNAs) have been associated with the clinical behavior of a vast spectrum of human tumors, providing an extensive resource of potential diagnostic and prognostic biomarkers. Although similar principles are now being applied with great success in other species, their relevance to feline molecular oncology has not yet been investigated in any detail. We report the construction of a genomic microarray platform for detection of recurrent CNAs in feline tumors through cytogenetic assignment of 210 large-insert DNA clones selected at intervals of ∼15 Mb from the feline genome sequence assembly. Microarray-based profiling of 19 ISAS and 27 non-ISAS cases identified an extensive range of genomic imbalances that were highly recurrent throughout the combined panel of 46 sarcomas. Deletions of two specific regions were significantly associated with the non-ISAS phenotype. Further characterization of these regions may ultimately permit molecular distinction between ISAS and non-ISAS, as a tool for predicting tumor behavior and prognosis, as well as refining means for therapeutic intervention.






Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.Abbreviations
- BAC:
-
Bacterial artificial chromosome
- BLAST:
-
Basic Local Alignment Search Tool
- BLAT:
-
BLAST-like alignment tool
- CNA:
-
Copy number aberration
- DSH/DMH/DLH:
-
Domestic short/medium/long hair
- FBS:
-
Fetal bovine serum
- FCA:
-
Felis catus
- FeLV:
-
Feline leukemia virus
- FFPE:
-
Formalin-fixed paraffin-embedded
- FISH:
-
Fluorescence in situ hybridization
- H&E:
-
Hematoxylin and eosin
- ISAS:
-
Injection-site-associated sarcoma
- Mb:
-
Megabase
- NCBI:
-
National Center for Biotechnology Information
- RPCI:
-
Roswell Park Cancer Institute
- UCSC:
-
University of California Santa Cruz
References
AVMA (2007) US pet ownership and demographics sourcebook. American Veterinary Medical Association, Schaumburg
Beck TW, Menninger J, Voigt G et al (2001) Comparative feline genomics: a BAC/PAC contig map of the major histocompatibility complex class II region. Genomics 71:282–295
Breen M, Modiano JF (2008) Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans—man and his best friend share more than companionship. Chromosome Res 16:145–154
Breen M, Hitte C, Lorentzen TD et al (2004) An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics 5:65–75
Cho KW, Okuda M, Endo Y et al (1997a) Assignment of the cat p53 tumor suppressor gene (TP53) to cat chromosome E1p14→p13 by fluorescence in situ hybridization. Cytogenet Cell Genet 79:145–146
Cho KW, Satoh H, Youn HY et al (1997b) Assignment of the feline c-myc gene (MYC) to cat chromosome F2q21.2 by fluorescence in situ hybridization. Cytogenet Cell Genet 78:135–136
Cho KW, Satoh H, Youn HY et al (1997c) Assignment of the cat immunoglobulin heavy chain genes IGHM and IGHG to chromosome B3q26 and T cell receptor chain gene TCRG to A2q12→q13 by fluorescence in situ hybridization. Cytogenet Cell Genet 79:118–120
Courtay-Cahen C, Platt SR, De Risio L, Starkey MP (2008) Preliminary analysis of genomic abnormalities in canine meningiomas. Vet Comp Oncol 6:182–192
Couto SS, Griffey SM, Duarte PC, Madewell BR (2002) Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet Pathol 39:33–41
Davis BW, Raudsepp T, Pearks Wilkerson AJ et al (2009) A high-resolution cat radiation hybrid and integrated FISH mapping resource for phylogenomic studies across Felidae. Genomics 93:299–304
Devitt JJ, Maranon DG, Ehrhart EJ et al (2009) Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma. Cytogenet Genome Res 124:12–18
Doddy FD, Glickman LT, Glickman NW, Janovitz EB (1996) Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol 114:165–174
Fujino Y, Mizuno T, Masuda K et al (2001a) Assignment of the feline Fas (TNFRSF6) gene to chromosome D2p13→p12.2 by fluorescence in situ hybridization. Cytogenet Cell Genet 95:122–124
Fujino Y, Mizuno T, Masuda K et al (2001b) Assignment of the feline Fas ligand gene (TNFSF6) to chromosome F1q12→q13 by fluorescence in situ hybridization. Cytogenet Cell Genet 94:92–93
Goh K, Smith RA, Proper JS (1981) Chromosomal aberrations in leukemic cats. Cornell Vet 71:43–46
Grindem CB, Buoen LC (1989) Cytogenetic analysis in nine leukaemic cats. J Comp Pathol 101:21–30
Hendrick MJ, Goldschmidt MH (1991) Do injection site reactions induce fibrosarcomas in cats? J Am Vet Med Assoc 199:968
Hendrick MJ, Kass PH, McGill LD, Tizard IR (1994) Postvaccinal sarcomas in cats. J Natl Cancer Inst 86:341–343
Hershey AE, Sorenmo KU, Hendrick MJ, Shofer FS, Vail DM (2000) Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216:58–61
Hoots E, McNeil E, LaRue S (2001) Characterization of genetic alterations in feline vaccine-associated sarcoma using whole chromosome paint probes (abstr). In American College of Veterinary Internal Medicine, pp. 83
Kalat M, Mayr B, Schleger W, Wagner B, Reifinger M (1991) Chromosomal hyperdiploidy in a feline sarcoma. Res Vet Sci 51:227–228
Kass PH (2004) Methodological issues in the design and analysis of epidemiological studies of feline vaccine-associated sarcomas. Anim Health Res Rev 5:291–293
Kass PH, Spangler WL, Hendrick MJ et al (2003) Multicenter case control study of risk factors associated with development of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 223:1283–1292
Kent WJ (2002) BLAT—the BLAST-like alignment tool. Genome Res 12:656–664
Kent WJ, Sugnet CW, Furey TS et al (2002) The human genome browser at UCSC. Genome Res 12:996–1006
Kirpensteijn J (2006) Feline injection site-associated sarcoma: Is it a reason to critically evaluate our vaccination policies? Vet Microbiol 117:59–65
Macy DW (2004) Feline vaccine-associated sarcomas: progress? Anim Health Res Rev 5:287–289
Mayr B, Hofstadler E, Schleger W, Reifinger M, Eisenmenger E (1994) Trisomy D1, marker F1: new cytogenetic findings in two cases of feline fibrosarcoma. Zentralbl Veterinarmed A 41:197–201
Mayr B, Ortner W, Reifinger M, Loupal G (1995) Loss of chromosome B2-material in three cases of feline mammary tumours. Res Vet Sci 59:61–63
Mayr B, Bockstahler B, Loupal G, Reifinger M, Schleger W (1996) Cytogenetic variation between four cases of feline fibrosarcoma. Res Vet Sci 61:268–270
Mayr B, Wegscheider H, Reifinger M, Jugl T (1998) Cytogenetic alterations in four feline soft-tissue tumours. Vet Res Commun 22:21–29
Mayr B, Jugl M, Brem G, Reifinger M, Loupal G (1999) Cytogenetic variation in six cases of feline mammary tumours. Zentralbl Veterinarmed A 46:367–377
McNeil E, Hoots E, LaRue S (2001) Characterization of chromosomal aberrations in feline vaccine-associated sarcoma using comparative genomic hybridization (abstr). In American College of Veterinary Internal Medicine, pp. 84
Menotti-Raymond M, David VA, Schaffer AA et al (2008) An autosomal genetic linkage map of the domestic cat, Felis silvestris catus. Genomics 93:305–313
Minke JM, Cornelisse CJ, Stolwijk JA et al (1990) Flow cytometric DNA ploidy analysis of feline mammary tumors. Cancer Res 50:4003–4007
Mitelman F, Johansson B, Mertens FE (2008) Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
Moizhess TG (2008) Carcinogenesis induced by foreign bodies. Biochemistry (Mosc) 73:763–775
Morrison WB, Starr RM (2001) Vaccine-associated feline sarcomas. J Am Vet Med Assoc 218:697–702
Munday JS, Stedman NL, Richey LJ (2003) Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas. Vet Pathol 40:288–293
Murphy WJ (2006) The feline genome. Genome Dyn 2:60–68
Pfister S, Remke M, Benner A et al (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27:1627–1636
Pontius JU, Mullikin JC, Smith DR et al (2007) Initial sequence and comparative analysis of the cat genome. Genome Res 17:1675–1689
Rettenberger G, Klett C, Zechner U et al (1995) ZOO-FISH analysis: cat and human karyotypes closely resemble the putative ancestral mammalian karyotype. Chromosome Res 3:479–486
Ruiz-Herrera A, Robinson TJ (2008) Evolutionary plasticity and cancer breakpoints in human chromosome 3. Bioessays 30:1126–1137
Sargan DR, Milne BS, Hernandez JA et al (2005) Chromosome rearrangements in canine fibrosarcomas. J Heredity 96:766–773
Schottenfeld D, Beebe-Dimmer JL, Vigneau FD (2009) The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 19:58–69
Shepherd AJ (2008) Results of the 2007 AVMA survey of US pet-owning households regarding use of veterinary services and expenditures. J Am Vet Med Assoc 233:727–728
Swanton C, Caldas C (2009) Molecular classification of solid tumours: towards pathway-driven therapeutics. Br J Cancer 100:1517–1522
Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M (2003) Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 89:1530–1537
Thomas R, Scott A, Langford CF et al (2005) Construction of a 2-Mb resolution BAC microarray for CGH analysis of canine tumors. Genome Res 15:1831–1837
Thomas R, Duke SE, Bloom SK et al (2007) A cytogenetically characterized, genome-anchored 10-Mb BAC set and CGH array for the domestic dog. J Heredity 98:474–484
Thomas R, Duke SE, Karlsson EK et al (2008) A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis. Cytogenet Genome Res 122:110–121
Thomas R, Duke SE, Wang HJ et al (2009a) ‘Putting our heads together’: insights into genomic conservation between human and canine intracranial tumors. J Neurooncol 94:333–349
Thomas R, Wang HJ, Tsai PC et al (2009b) Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res 17:365–377
VAFSTF:The Vaccine-Associated Feline Sarcoma Task Force (2005) The current understanding and management of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 226:1821–1842
Vascellari M, Melchiotti E, Bozza MA, Mutinelli F (2003) Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. J Vet Med A Physiol Pathol Clin Med 50:286–291
Waly NE, Gruffydd-Jones TJ, Stokes CR, Day MJ (2005) Immunohistochemical diagnosis of alimentary lymphomas and severe intestinal inflammation in cats. J Comp Pathol 133:253–260
Wienberg J, Stanyon R, Nash WG et al (1997) Conservation of human vs. feline genome organization revealed by reciprocal chromosome painting. Cytogenet Cell Genet 77:211–217
Winkler S, Reimann-Berg N, Murua Escobar H et al (2006) Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer. Cancer Genet Cytogenet 169:154–158
Acknowledgements
We thank Katie Saylor and Emily Smith for technical assistance and Dr. Steven Suter for his clinical advice and expertise. We are grateful to Drs. Steve O’Brien, Sagarika Kanjilal, Naoya Yuhki, and Vivek Kapur for assistance with retrieval of feline DNA sequences, and we gratefully acknowledge Dr. Peter de Jong for provision of feline BAC clones. We thank Sandra Horton and the NCSU Histology Service for their invaluable assistance with retrieving clinical samples and data and thank the owners and veterinarians who contributed feline clinical samples. This study was supported by funding from the Morris Animal Foundation (D06FE-308 awarded to RT) and was sponsored by the Blue Buffalo Foundation for Cancer Research and Carolyn S. Norgren. KLT is a European Science Foundation EURYI award recipient.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: Dean A. Jackson
Electronic supplementary material
Below is the link to the electronic supplementary material.
S1
Signalment and aCGH data for all sarcoma cases analyzed (n = 46). The breed, age, and gender of each case are shown at the top of the chart, along with the anatomical location of the tumor. ISAS cases are listed to the left, and non-ISAS cases to the right. The first two columns indicate the chromosome and megabase location of arrayed BAC clones, which are listed in genomic order. Colored cells indicate the copy number status at each locus in each tumor case, based on the tumor DNA/reference DNA fluorescence intensity (red cells indicates genomic loss, test/reference ≤ 0.85:1; green cells indicates genomic gain, test/reference ≥ 1.15:1; yellow cells indicates genomic balance). M male, F female, DSH domestic short hair, DMH domestic medium hair, DLH domestic long hair (PDF 180 kb)
Rights and permissions
About this article
Cite this article
Thomas, R., Valli, V.E., Ellis, P. et al. Microarray-based cytogenetic profiling reveals recurrent and subtype-associated genomic copy number aberrations in feline sarcomas. Chromosome Res 17, 987–1000 (2009). https://doi.org/10.1007/s10577-009-9096-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10577-009-9096-0


